A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia

NCT04508621 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

514

Enrollment

INDUSTRY

Sponsor class

Conditions

Fibromyalgia

Interventions

DRUG: TNX-102 SL
DRUG: Placebo SL Tablet

Sponsor

Tonix Pharmaceuticals, Inc.